Filter
1111
Filtered Results: 1111
Text search:
vaccine
trial
Featured
Recommendations
139
New Publications
237
Language
Document type
No document type
479
Studies & Reports
208
Guidelines
192
Manuals
68
Fact sheets
65
Strategic & Response Plan
41
Situation Updates
18
Training Material
14
Resource Platforms
12
Infographics
6
Videos
5
Brochures
2
App
1
Countries / Regions
Global
51
India
37
Kenya
26
Sierra Leone
25
South Africa
23
Liberia
21
Nigeria
21
West and Central Africa
18
Ethiopia
17
Western and Central Europe
17
Brazil
16
East and Southern Africa
16
Uganda
14
Africa
14
Latin America and the Carribbean
13
Congo, Democratic Republic of
11
Eastern Europe
11
Russia
10
Guinea
9
Ghana
9
Zambia
9
Ukraine
9
South Sudan
8
Rwanda
8
Malawi
8
Philippines
7
Nepal
7
Germany
7
Tanzania
7
Mozambique
7
Middle East and North Africa
7
South–East Asia Region
7
Zimbabwe
6
Syria
6
Bangladesh
6
Cambodia
4
Namibia
4
Myanmar / Burma
4
Asia
4
Vietnam
4
Burkina Faso
3
Senegal
3
USA
3
Lebanon
3
Thailand
3
Indonesia
3
Chile
3
Eastern Europe and Central Asia
3
Paraguay
3
United Kingdom
3
Guinea-Bissau
2
Cameroon
2
Jordan
2
Turkey
2
China
2
Sudan
2
Argentina
2
Botswana
2
Angola
2
Lesotho
2
Spain
2
Mali
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Niger
1
Haiti
1
Pakistan
1
Iraq
1
Gambia
1
Malaysia
1
Papua New Guinea
1
Central African Republic
1
Peru
1
Eswatini/ Swaziland
1
Honduras
1
Ecuador
1
Yemen
1
Western Pacific Region
1
Venezuela
1
Southern Africa
1
Laos
1
Bulgaria
1
Gabon
1
Japan
1
France
1
Tunisia
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
296
Clinical Guidelines
145
Women & Child Health
64
Public Health
58
Key Resources
23
Pharmacy & Technologies
14
Capacity Building
4
Toolboxes
COVID-19
282
TB
91
HIV
81
Ebola
67
Rapid Response
55
NTDs
44
AMR
31
Pharmacy
26
Global Health Education
16
Refugee
15
Mental Health
15
Planetary Health
14
Health Financing Toolbox
14
Conflict
12
NCDs
12
Polio
11
Zika
11
Caregiver
11
Cholera
10
Disability
2
Natural Hazards
1
Learn what scientists look for in the different phases of a clinical trial for a vaccine. What does it mean when a vaccine ... is halted due to an adverse event? WHO’s Dr Kate O’Brien explains in Science in 5 this week
the Lancet : Published Online July 31, 2015 http://dx.doi.org/10.1016/S0140-6736(15)61117-5
The conduct of COVID-19 vaccine trials in the context of a candidate vaccine being issued with Emergency Use Designation raises challenging ethical...
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that suf...
The Lancet. Published Online December 22, 2016 http://dx.doi.org/10.1016/S0140-6736(16)32621-6. Open Access
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Published:February 02, 2021DOI:https://doi.org/10.1016/S0140-6736(21)00234-8
COVID-19 vaccine tracker and landscape
recommended
The COVID-19 vaccine tracker and landscape compiles detailed information of each COVID-19 vaccine candidate in development by closely monitoring their progress through the pipeline.
The COVID-19 ...
Exciting news this week with @Pfizer reporting their mRNA vaccine is 90% effective, based on their Phase III clinical trial data. Dr. Tom looks inside the virus to break down how mRNA vaccines work,...
Manufacturers:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant)]
...
10 May 2021. Manufactureres:
SK Bioscience Co. Ltd. [COVID-19 Vaccine (ChAdOx1-S [recombinant])]
Serum Institute of India Pvt. Ltd. [COVISHIELD™, ChAdOx1 nCoV-19 Corona Virus Vaccine (R...
Early data from US biotech Moderna has revealed that its Covid-19 vaccine candidate is 94.5 per cent effective, raising hopes that a range of immunisations will be available to help end the pandemic.
The interim analysis of the ..., currently known as mRNA-1273, comes after 95 trial participants contracted Covid-19, including just five who were given the coronavirus jab.
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB ... for neonates and
infants with improved safety and efficacy.
3. A therapeutic vaccine to improve TB
treatment outcomes
Sierra Leone Trial to Introduce a Vaccine against Ebola (STRIVE)
This document is part three in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. Part two focused on the ingredients in a ... and the three clinical trial phases.
This document outlines the next part of the vaccine journey: the steps from completing the clinical trial phases through to distribution.
This article is part two in a series of explainers on vaccine development and distribution. Part one focused on how vaccines work to protect our bodies from disease-carrying germs. This article focuses on the ingredients in a ... and the three clinical trial phases. Part three outlines the next part of the vaccine journey: the steps from completing the clinical trial phases through to distribution
Available in English, French, Spanish, Arabic, Chinese and Russian
This article is part four in a series of explainers on vaccine development and distribution.
Part one focused on how vaccines work to protect our bodies from disease-carrying germs.
Part two focused on the ingredients in a ... and the three clinical trial phases.
Part three focused on the steps from completing the clinical trial phases through to distribution.
This document outlines the different types of vaccines.
Available in English, French, Spanisch, Arabic, Chinese and Russian
COVAXINTM, India's indigenous COVID-19 vaccine by Bharat Biotech is developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV). The indigenous, inactivated ... is developed and manufactured in Bharat Biotech's BSL-3 (Bio-Safety Level 3) high containment facility.
The vaccine received DCGI approval for Phase I & II Human Clinical Trials and the trials commenced across India from July, 2020.
After successful completion of the interim analysis from the Phase 1 & 2 clinical trials of COVAXINTM, Bharat Biotech received DCGI approval for Phase 3 clinical trials in 26,000 participants in over 25 centres across India.
WHO strongly recommends discontinuation of the nerve tissue vaccine, and replacement with modern concentrated and purified cell culture derived vaccines (CCDV) and embryonated eggbased rabies vaccines.
These vaccines must comply with WHO criteria f...
Human African trypanosomiasis (HAT), also called sleeping sickness, is a parasitic infection that almost invariably progresses to death, unless treatment is provided. HAT caused devastating epidemics during the 20th century. Thanks to sustained and coordinated efforts during the past 15 years the nu...
